• Shaping the Future of MS Treatment: The Role of Generics and Biosimilars with high cost drugs pharmacist Lucy Wessels

  • Apr 10 2024
  • Duración: 35 m
  • Podcast

Shaping the Future of MS Treatment: The Role of Generics and Biosimilars with high cost drugs pharmacist Lucy Wessels

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this episode we delve into the evolving landscape of multiple sclerosis treatment, focusing on generics and biosimilars. It features a conversation with pharmacist Lucy Wessels, highlighting the safety, effectiveness, and cost benefits of generics and biosimilars in managing MS. The discussion emphasizes the importance of patient education, collaborative decision-making with healthcare providers, and dispelling misconceptions like the 'nocebo' effect around these treatment option.

    00:00 Welcome and Introduction to the Episode
    01:06 Understanding Generics and Biosimilars in MS Treatment
    03:42 Diving Deeper: The Difference Between Generics and Biosimilars
    11:58 Addressing Concerns: Side Effects and Tolerability
    14:34 Enhancing Patient Understanding and Acceptance
    20:22 The Nocebo Effect and Its Impact on Treatment Perception
    24:34 Future of MS Treatment: Embracing Generics and Biosimilars
    31:52 Concluding Thoughts and Key Takeaways

    Become a supporter of this podcast: https://www.spreaker.com/podcast/beewellwithms-podcast-by-dr-agne-straukiene--5762905/support.
    Más Menos
Hygiene & Healthy Living
Más Menos

Lo que los oyentes dicen sobre Shaping the Future of MS Treatment: The Role of Generics and Biosimilars with high cost drugs pharmacist Lucy Wessels

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles